A structured lifestyle program improved heart and metabolic risk factors and thinking skills more than a self-guided program, with consistent results across age, genetic risk and sex
BOSTON, Nov. 18, 2026 /PRNewswire/ -- Can improving heart health improve brain health? New results from the Alzheimer's Association U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) say yes.
In the two-year trial, a structured lifestyle program improved heart health and metabolic risk factors, including body mass index, diastolic blood pressure, resting heart rate, and cholesterol and triglyceride levels, more than a self-guided program. Improvements in cardiometabolic risk factors were linked to better cognition in both groups. The structured intervention benefit was consistent for men and women, for participants younger and older than 70, and between individuals with and without the APOE4 gene that is associated with higher Alzheimer's risk.
"Improving heart and metabolic health risk factors is one of the pathways through which our multidomain lifestyle program improves cognition," said Rachel Anne Whitmer, Ph.D., chief of the Division of Epidemiology, director of the Population Brain Health Lab, co-director of the Alzheimer's Disease Center at UC Davis School of Medicine, and a principal investigator of U.S. POINTER. "In this study, people who showed more improvement in many of these risk factors also improved the most on cognition."
The results were reported today at the Clinical Trials on Alzheimer's Disease 2026 conference in Boston.
U.S. POINTER is a single-blind, multicenter, randomized clinical trial that enrolled 2,111 participants (mean age 68.2 years; 68.9% female) at five clinical sites between May 2019 and March 2023. Participants were at elevated risk for cognitive decline due to sedentary lifestyle, suboptimal diet and heart health issues, or demographic. They were randomly assigned to a structured or self-guided lifestyle intervention targeting physical activity, adherence to the MIND diet, social and cognitive engagement, and health monitoring. The two interventions differed in format, support and accountability.
Observational studies have linked cardiometabolic risk factors to a higher risk of cognitive decline and dementia, particularly when they are present in midlife. In U.S. POINTER, heart health and metabolic risk factors improved in both interventions over 24 months, and the structured group improved more on eight of the 10 measures.
Compared with the self-guided group, the structured group had significantly greater reductions in body mass index, waist circumference, HbA1c, diastolic blood pressure, resting heart rate, total cholesterol, LDL cholesterol and triglycerides. Systolic blood pressure and HDL cholesterol differences were not reported as significant.
"We know from observational studies that these risk factors, especially in midlife, are associated with dementia risk," Whitmer said. "Now we show that a structured lifestyle program can change them within 24 months, that the benefit was consistent across age, APOE4 genotype and sex, and that improving them was linked to better cognition in both intervention groups."
"Strengthening heart and metabolic health led to better cognition over the two years of this study," said Heather M. Snyder, Ph.D., Alzheimer's Association senior vice president of medical and scientific relations and a U.S. POINTER principal investigator. "The important question ahead is what sustaining those changes could mean over the years to come, and the U.S. POINTER Alumni Extension study is designed to help answer it."
The U.S. POINTER Alumni Extension allows for four more years of observation to assess longer-term impacts of the study's interventions on cognitive health and dementia risk. In addition to its investments to date, the Alzheimer's Association will invest more than $40 million over the next four years to continue to follow U.S. POINTER participants, and to bring the U.S. POINTER brain health recipe to communities across America.
About the U.S. POINTER Trial
Initial U.S. POINTER results, published in JAMA and reported at the Alzheimer's Association International Conference 2025, showed that two-year lifestyle programs targeting a combination of regular physical activity, healthy nutrition, cognitive and social challenge, and health monitoring improved global cognition in a representative U.S. population of older adults at risk of cognitive decline. Participants following a program including structured support and accountability improved significantly more than a self-guided program. The benefit was consistent between APOE4 carriers and noncarriers and across sex, age and baseline cardiovascular health status. A majority of participants agreed to join the U.S. POINTER Alumni Extension.
U.S. POINTER and the Alumni Extension are funded by the Alzheimer's Association. Additional support comes from the National Institute on Aging for add-on studies of brain imaging, vascular measures, sleep and the gut microbiome.
About the Alzheimer's Association
The Alzheimer's Association is a worldwide voluntary health organization dedicated to Alzheimer's care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.
SOURCE Alzheimer's Association

Share this article